Skip to content

Clinical trials

Terminated Genetic Diseases, Inborn trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Status: Terminated Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20061
20091
20113
20141
20151
20161
20181
20191
20216

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
HemoShear Therapeutics2
National Center for Research Resources (NCRR)2
Novartis Pharmaceuticals2
Fairview University Medical Center1
Fred Hutchinson Cancer Center1
Kyntra Bio1
Laboratoires Thea1
ModernaTX, Inc.1
National Cancer Institute (NCI)1
National Human Genome Research Institute (NHGRI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn21
Metabolic Diseases4
Metabolism, Inborn Errors4
Rare Diseases4
Muscular Dystrophy, Duchenne3
Musculoskeletal Diseases3
Nervous System Diseases3
Anemia, Aplastic2
Cystic Fibrosis2
Fragile X Syndrome2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.